NCT02606422 Date of Document: March 8, 2024 - ClinicalTrials.gov
Results: Overall, tDCS stimulation of DLPFC could alleviate the clinical symptoms of schizophrenia, depression, drug addiction, attention ...
Evidence-based guidelines on the therapeutic use of transcranial ...As a conclusion, the present level of evidence for the analgesic effect of M1 stimulation is weaker for tDCS than for rTMS (Lefaucheur et al., ... Evidence-based guidelines on the therapeutic use of transcranial ...Delivered to the motor cortex of healthy subjects, anodal tDCS increases the excitability of the underlying cortex, as revealed by an increase ... Topical preparations for the treatment of psoriasis in primary care:? 0.01% Fluocinolone (Synalar) cream, lot. ? 0.05% Alclometasone oint. ? 0.005% Fluticasone propionate ointment (Cultivate). ? 0.1% Mometasone furoate ointment.
Autres Cours:
